The Beauty Health Company SKIN Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by The Beauty Health Company in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: The Beauty Health Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Beauty Health Company's debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Beauty Health Company's debt issuance cost amortization?
- The Beauty Health Company (SKIN) reported debt issuance cost amortization of $1.01M in Q1 2026.
- How has The Beauty Health Company's debt issuance cost amortization changed year-over-year?
- The Beauty Health Company's debt issuance cost amortization increased by 28.5% year-over-year, from $786K to $1.01M.
- What is the long-term trend for The Beauty Health Company's debt issuance cost amortization?
- Over 3 years (2022 to 2025), The Beauty Health Company's debt issuance cost amortization has grown at a -4.9% compound annual growth rate (CAGR), from $4.23M to $3.64M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).